ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.
- DOI
- 10.1158/1535-7163.mct-10-0019
- Published
- 2010 Jun
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- cautionRetraction Watch correction: 1 correction notice matched this DOI.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-10-0019,
title = {ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.},
author = {Nautiyal J and Yu Y and Aboukameel A and Kanwar SS and Das JK and Du J and Patel BB and Sarkar FH and Rishi AK and Mohammad RM and Majumdar AP},
year = {2010},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-10-0019},
url = {https://doi.org/10.1158/1535-7163.mct-10-0019}
}RIS
TY - JOUR TI - ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells. AU - Nautiyal J AU - Yu Y AU - Aboukameel A AU - Kanwar SS AU - Das JK AU - Du J AU - Patel BB AU - Sarkar FH AU - Rishi AK AU - Mohammad RM AU - Majumdar AP PY - 2010 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-10-0019 UR - https://doi.org/10.1158/1535-7163.mct-10-0019 ER -
APA
J, N., Y, Y., A, A., SS, K., JK, D., J, D., BB, P., FH, S., AK, R., RM, M., & AP, M. (2010). ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-10-0019
Source records
- pubmed · retrieved 2026-09-26T17:18:19.760Z